Why Biopharma's Tech Adoption Seems Slow

Biopharma is a relatively conservative and highly regulated industry, which means change happens slowly. In this segment from the Bioprocess Online Live event “How Digital Tools Are Accelerating Biopharma Development,” panelists Moiz Diwan, Ph.D. (AbbVie), and Kat Kozyrytska (independent technology consultant) discuss the factors slowing biopharma’s adoption of advanced technologies compared to other sectors and advocate for industry-wide collaboration to move the industry forward.